Since ABT-263 is an inhibitor of the anti-apoptotic protein Bcl-2 family, it is thought that ABT-263 induces caspase-mediated apoptosis of irradiated cancer cells by inhibiting Bcl-2. The gene discussed is BCL2; the disease is cancer.